A Phase I, randomized, single-blind, placebo-controlled, single-center study in healthy male volunteers to assess the safety, tolerability, pharmacokinetics and pharmacodynamics after repeated oral doses of AZD2207
Study identifier:D3180C00002
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Phase I, randomized, single-blind, placebo-controlled, single-center study in healthy male volunteers to assess the safety, tolerability, pharmacokinetics and pharmacodynamics after repeated oral doses of AZD2207
Medical condition
obesity
Phase
Phase 1
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Jul 2007
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
